Rytary on HealthSpring Extra Rx (S5617-373)
carbidopa-levodopa extended-release
Covered, with step therapy.
Tier 4 (non-preferred drug). No quantity limit.
30%
Patient pays / month, after deductible
30%
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
RYTARY 95/23.75 mg Capsule, Extended Release at a preferred retail pharmacy. Other covered strengths are listed below.
Prior authNot required· Step therapy applies· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| RYTARY 95/23.75 mg Capsule, Extended Release | 4 | 30% | ST |
| RYTARY 145/36.25 mg Capsule, Extended Release | 4 | 30% | ST |
| RYTARY 195/48.75 mg Capsule, Extended Release | 4 | 30% | ST |
| RYTARY 245/61.25 mg Capsule, Extended Release | 4 | 30% | ST |
Other Parkinson's drugs on this plan
Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5617-373